AOD-9604 and tesamorelin lead the research covered in Peptides for Weight Loss - studied for fat metabolism and visceral fat reduction respectively - alongside CJC-1295/Ipamorelin examined for GH-driven lipolysis. All are research compounds for laboratory use, not FDA-approved weight loss products.